Stock Market

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

Capricor Therapeutics

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an eight-year high. The dramatic ascent follows the announcement of overwhelmingly positive top-line results from its pivotal Phase 3 HOPE-3 study for

By MarketMinute
ADP Job Data Shakes Markets: Dow and S&P 500 Rebound on Rate Cut Hopes, Nasdaq Grapples with AI Demand Doubts Amidst Private Sector Weakness

ADP Jobs Data

ADP Job Data Shakes Markets: Dow and S&P 500 Rebound on Rate Cut Hopes, Nasdaq Grapples with AI Demand Doubts Amidst Private Sector Weakness

New York, NY – December 3, 2025 – The U.S. financial markets experienced a turbulent day as the latest ADP National Employment Report for November 2025 revealed an unexpected contraction in private sector employment, sending initial jitters through investors. While major indices like the Dow Jones Industrial Average and the S&

By MarketMinute